All stock lists
Unlock the score
Ascendis Pharma A/S (NASDAQ:ASND)
DK · Delayed Price · Currency is USD
Healthcare · Biotechnology
244.74+1.37 (+0.56%)
Market cap
$15.3B
Insider Score
Analyst consensus
Listed since
Jan 28, 2015
Website
Insider Score
/ 100
ASND Insider Score
Ascendis Pharma A/S has a live Insider Score.
Scored on 2 qualifying trades from 1 insider in the last 90 days.
ASND Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 344.90 M | 250.66 M | 245.18 M | 213.63 M | 158.04 M | 100.95 M |
| Revenue Growth (YoY) | 118.23 % | 148.29 % | 40.98 % | 269.40 % | 339.04 % | 5.28 % |
| Cost of Revenue | 32.30 M | 21.62 M | 27.20 M | 22.35 M | 31.45 M | 17.52 M |
| Gross Profit | 312.61 M | 229.03 M | 217.98 M | 191.28 M | 126.60 M | 83.44 M |
| SG&A Expense | 174.52 M | 146.18 M | 133.20 M | 111.69 M | 105.71 M | 95.65 M |
| R&D Expense | 74.65 M | 57.63 M | 74.98 M | 66.88 M | 71.99 M | 86.60 M |
| Operating Expenses | 249.17 M | 203.81 M | 208.18 M | 180.28 M | 179.55 M | 187.65 M |
| Operating Income | 63.43 M | 25.22 M | 9.80 M | 11.00 M | -52.95 M | -104.21 M |
| Pretax Income | 233.90 M | -48.97 M | -26.45 M | -57.37 M | -35.01 M | -93.56 M |
| Tax Provision | 23.51 M | -688.66 M | 6.79 M | 3.62 M | 3.85 M | 1.06 M |
| Net Income | 210.40 M | 639.69 M | -33.25 M | -60.99 M | -38.85 M | -94.63 M |
| EPS (Basic) | 3.27 | 10.37 | -0.54 | -1.00 | -0.64 | -1.58 |
| EPS (Diluted) | 3.08 | 9.91 | -0.54 | -1.00 | -0.82 | -1.58 |
| Shares Outstanding | 64.34 M | 61.68 M | 61.38 M | 60.99 M | 60.45 M | 60.02 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.